Chunguang Yang
Biographic Data
| ID | 7291545 |
|---|---|
| NAME | Chunguang Yang |
| GIVEN NAMES | Chunguang |
| FAMILY NAME | Yang |
| SIGNATURE | YANG C |
| AFFILIATIONS | Huazhong University of Science and Technology |
| ORCID | 0000-0002-3882-4940 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Effectiveness of Arbidol for Covid-19 Prevention in Health Professionals
Background Frontline health professionals are a COVID-19-susceptible population during the outbreak of COVID-19, but prophylactic drugs against SARS-CoV-2 infection are to be explored. Method Frontline health professionals diagnosed with COVID-19 before February 9, 2020 in Tongji Hospital, Wuhan, China and the same amount of controls in the uninfected group were included in this study. Clinical and laboratory data were collected with standardised…
Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With Covid-19 Pneumonia
Background: Clinical characteristics of the coronavirus disease 2019 (COVID-19) have been well studied, while effective predictors for clinical outcome and research on underlying mechanism are scare. Methods: Hospitalized COVID-19 pneumonia patients with definitive clinical outcome (cured or died) were retrospectively studied. The diagnostic performance of the leucocyte subsets and other parameters were compared using the area under the receiver …
Lariciresinol-4-O-β-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response
No prominent works on this page.
Lariciresinol-4-O-β-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response
Effectiveness of Arbidol for Covid-19 Prevention in Health Professionals
Background Frontline health professionals are a COVID-19-susceptible population during the outbreak of COVID-19, but prophylactic drugs against SARS-CoV-2 infection are to be explored. Method Frontline health professionals diagnosed with COVID-19 before February 9, 2020 in Tongji Hospital, Wuhan, China and the same amount of controls in the uninfected group were included in this study. Clinical and laboratory data were collected with standardised…
Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With Covid-19 Pneumonia
Background: Clinical characteristics of the coronavirus disease 2019 (COVID-19) have been well studied, while effective predictors for clinical outcome and research on underlying mechanism are scare. Methods: Hospitalized COVID-19 pneumonia patients with definitive clinical outcome (cured or died) were retrospectively studied. The diagnostic performance of the leucocyte subsets and other parameters were compared using the area under the receiver …
Medicine (3 works) · Biology (2 works) · COVID-19 Clinical Research Studies (2 works) · Internal Medicine (2 works) · Long-Term Effects of COVID-19 (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Virology (2 works) · Absolute neutrophil count (1 work) · Area under the curve (1 work) · Chemistry (1 work)